Dataset Information

Large-scale comparison of machine learning methods for drug target prediction on ChEMBL.

ABSTRACT: Deep learning is currently the most successful machine learning technique in a wide range of application areas and has recently been applied successfully in drug discovery research to predict potential drug targets and to screen for active molecules. However, due to (1) the lack of large-scale studies, (2) the compound series bias that is characteristic of drug discovery datasets and (3) the hyperparameter selection bias that comes with the high number of potential deep learning architectures, it remains unclear whether deep learning can indeed outperform existing computational methods in drug discovery tasks. We therefore assessed the performance of several deep learning methods on a large-scale drug discovery dataset and compared the results with those of other machine learning and target prediction methods. To avoid potential biases from hyperparameter selection or compound series, we used a nested cluster-cross-validation strategy. We found (1) that deep learning methods significantly outperform all competing methods and (2) that the predictive performance of deep learning is in many cases comparable to that of tests performed in wet labs (i.e., in vitro assays).

SUBMITTER: Mayr A

PROVIDER: S-EPMC6011237 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Large-scale comparison of machine learning methods for drug target prediction on ChEMBL.

Mayr Andreas A Klambauer Günter G Unterthiner Thomas T Steijaert Marvin M Wegner Jörg K JK Ceulemans Hugo H Clevert Djork-Arné DA Hochreiter Sepp S

Chemical science 20180606 24

Deep learning is currently the most successful machine learning technique in a wide range of application areas and has recently been applied successfully in drug discovery research to predict potential drug targets and to screen for active molecules. However, due to (1) the lack of large-scale studies, (2) the compound series bias that is characteristic of drug discovery datasets and (3) the hyperparameter selection bias that comes with the high number of potential deep learning architectures, i ...[more]

PMID: 30155234

Similar Datasets

Project description:BackgroundMetagenomics is an approach to the characterization of microbial genomes via the direct isolation of genomic sequences from the environment without prior cultivation. The amount of metagenomic sequence data is growing fast while computational methods for metagenome analysis are still in their infancy. In contrast to genomic sequences of single species, which can usually be assembled and analyzed by many available methods, a large proportion of metagenome data remains as unassembled anonymous sequencing reads. One of the aims of all metagenomic sequencing projects is the identification of novel genes. Short length, for example, Sanger sequencing yields on average 700 bp fragments, and unknown phylogenetic origin of most fragments require approaches to gene prediction that are different from the currently available methods for genomes of single species. In particular, the large size of metagenomic samples requires fast and accurate methods with small numbers of false positive predictions.ResultsWe introduce a novel gene prediction algorithm for metagenomic fragments based on a two-stage machine learning approach. In the first stage, we use linear discriminants for monocodon usage, dicodon usage and translation initiation sites to extract features from DNA sequences. In the second stage, an artificial neural network combines these features with open reading frame length and fragment GC-content to compute the probability that this open reading frame encodes a protein. This probability is used for the classification and scoring of gene candidates. With large scale training, our method provides fast single fragment predictions with good sensitivity and specificity on artificially fragmented genomic DNA. Additionally, this method is able to predict translation initiation sites accurately and distinguishes complete from incomplete genes with high reliability.ConclusionLarge scale machine learning methods are well-suited for gene prediction in metagenomic DNA fragments. In particular, the combination of linear discriminants and neural networks is promising and should be considered for integration into metagenomic analysis pipelines. The data sets can be downloaded from the URL provided (see Availability and requirements section).

Dataset Information

Large-scale comparison of machine learning methods for drug target prediction on ChEMBL.

Publications

Large-scale comparison of machine learning methods for drug target prediction on ChEMBL.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets